Site icon pharmaceutical daily

The Generic Pharmaceutical Market in Kenya & Nigeria – Forecast to 2022: Greater Regulatory Control and a Shift of Focus Away from Costly & Branded Drugs will Increase Generic Drugs Market Share – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Generic
Pharmaceutical Market in Kenya and Nigeria, Forecast to 2022”

report has been added to ResearchAndMarkets.com’s
offering.

The African continent grapples with a huge burden of communicable
diseases, particularly HIV/AIDS, tuberculosis, and malaria. With African
governments facing major health financing challenges, a significant
proportion of these disease areas are financed by global aid
organizations that are also helping in poverty eradication in the
continent.

In parallel, with each passing year, the incidence of non-communicable
diseases has also been on the rise, along with the rising incomes of the
African people. With rising incomes, there is greater indulgence in
Westernised diets and unhealthy lifestyles that involve high alcohol
intake and tobacco smoking.

The pharmaceutical market in Africa has had to keep up with these
trends, providing the necessary medicines to combat the various diseases
affecting people in African countries. While branded medicines have
dominated the pharmaceutical market in the past decades, the current
situation seems to favour the generic alternatives instead, as these
achieve similar therapeutic outcomes.

Taking into consideration the major financing challenges mentioned
above, price becomes a key negotiating factor, resulting in governments
focusing on acquiring the cheapest drugs in the global market.

Moreover, the supply chains and distribution channels in countries such
as Kenya and Nigeria cater to more than 240 million people collectively.
These channels are often overwhelmed, particularly with the additional
challenges posed by an underdeveloped regulatory environment.

This has led to a stronger focus on developing local pharmaceutical
capabilities amongst both private and public sectors to cut down on
imports that have historically been subject to exchange rate
fluctuations. Interest in local manufacturing is growing, and
governments are slowly transforming the regulatory environment to create
a more conducive operating environment for pharmaceutical investors.

Research Scope

The study covers the following pharmaceutical therapeutic segments:
anti-infective, cancer, cardiovascular, central nervous system,
diabetes, and respiratory.

Research Highlights

Key Issues Addressed

Topics Covered

1. Executive Summary

2. Drivers and Restraints

3. Kenya Analysis

4. Nigeria Analysis

5. Growth Opportunities and Companies to Action

6. The Last Word

7. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/8sdjtl

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Pharmaceuticals,
Generic
Drugs

Exit mobile version